In your hands, our energy solutions have been setting the standard of patient care for nearly 50 years. But the challenges of today’s healthcare system demand we go further — with technologies that bring even greater efficiency to procedures.
That’s why we created the LigaSure™ retractable L-hook laparoscopic instrument. The only device of its kind, it delivers the benefits of([FOOTNOTE=Based on internal test report #RE00032739 Rev A, LigaSure™ Hook (LF5637, LF5644) validation surgeon evaluation report: independent surgeon feedback collected during Medtronic-sponsored cadaver and porcine lab conducted in Houston, Texas. February 2016.],[ANCHOR=],[LINK=]):
And that’s why the LigaSure™ L-hook instrument:
Surgeons who tested the instrument say the actions to grasp, seal, cut, deploy, and retract the Valleylab™ monopolar L-hook are simple and intuitive.1
Simply press a lever on the handle to deploy the L-hook — and deliver the precision of Valleylab™ monopolar dissection. When you’re ready to switch back to the Maryland jaws, just press the lever to retract the L-hook.([FOOTNOTE=LigaSure™ Retractable L-Hook Laparoscopic Sealer/Divider IFU [package insert]. Minneapolis, MN: Medtronic, 2016.],[ANCHOR=],[LINK=])
The Maryland-style jaws of the LigaSure™ retractable L-hook instrument:
And you get the speed and reliable performance of LigaSure™ vessel sealing technology.
The LigaSure™ retractable L-hook instrument:
And the L-hook is there when you need it, and out of the way when you don’t.
We’re redefining versatility. So you can keep your focus on the surgical site and protect patients from the risks of multiple instrument exchanges.([FOOTNOTE=Tebala G. Three-port laparoscopic cholecystectomy by harmonic dissection without cystic duct and artery clipping. Am J Surg. 2006;191:718-720.],[ANCHOR=],[LINK=])
Because the LigaSure™ retractable L-hook instrument combines the functionality of five devices in one. And gives you the reliable performance of both LigaSure™ technology([FOOTNOTE=Based on internal test report #RE00059404 Rev A, Market research – renal artery burst pressure comparison of LigaSure™ retractable L-hook (LF56XX) versus Harmonic Ace™*+7 and Olympus Thunderbeat™* using the ForceTriad™ energy platform and Valleylab™ FT10 energy platform on porcine renal arteries. Aug. 16–18, 2016, Aug. 29–Sept. 1, 2016.],[ANCHOR=],[LINK=]) and Valleylab™ monopolar dissection.
We’re transforming patient care with one of the most versatile surgical instruments ever created.
The LigaSure™ retractable L-hook laparoscopic sealer/divider offers the functionality of five devices — in one instrument1. And it combines the reliable performance of LigaSure™ vessel sealing technology4 with the precise dissection of Valleylab™ monopolar energy.
It’s also easy to use.
Surgeons who tested the device say the actions to grasp, seal, cut, deploy, and retract the Valleylab™ monopolar L-hook are simple and intuitive.1
LigaSure™ technology uses the body’s own collagen and elastin to create a permanent seal that can withstand three times normal systolic blood pressure.([FOOTNOTE=Based on internal test report #R0064457 Rev C, Verification report – LigaSure™ renal bench burst pressure evaluation of the Valleylab™ FT10.],[ANCHOR=],[LINK=])
With an average seal cycle of 1-4 seconds on vessels up to and including 7mm([FOOTNOTE=Based on internal report #RE00025819 Rev A, LigaSure™ data sources for VLFT10 white papers. Bench testing model used to evaluate sealing time. September 2015.],[ANCHOR=],[LINK=]), our technology can seal:
And it automatically stops energy delivery when the seal cycle is complete. So patients get a quality seal — every time.
The L-hook delivers the precise dissection of Valleylab™ monopolar energy2†. The result of nearly 50 years of experience collaborating with healthcare professionals in the surgical energy field.
Get a statistical explanation of standard deviation and why we utilize that measurement to support LigaSure™ technology.
See the full energy suite within the Valleylab™ energy portfolio, including LigaSure™ technology.
†29 out of 29 surgeons evaluated agreed
‡27 out of 29 surgeons evaluated agreed
€25 out of 29 surgeons evaluated agreed
Ω24 out of 29 surgeons evaluated agreed
¥26 out of 29 surgeons evaluated agreed
£28 out of 29 surgeons evaluated agreed